New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review).
about
High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cellsProliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment.FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6.Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?
P2860
Q36257678-744C7E98-B5C9-4A1A-98E8-02A3CE62E011Q37016586-7D81BF9F-5D6B-4376-AE66-927379CB5D59Q37287535-44436D82-6C6B-4D55-AC5B-65C0AF0323CAQ37317381-0EBF3B02-7B94-489C-9B57-41B7FD1AB716Q37407105-0B85C8E1-F3AC-427A-ABF9-FFE2B371E9ABQ47112399-BF24650F-E9EB-416C-8F3C-9A162C3B9564Q48128939-8BF365D2-C10B-4441-AABD-96BC6277473AQ51480749-4F389A61-264C-41E9-8D7C-A81C1C64D321Q54942423-3DEC17E3-0B8F-4154-B973-90D70ED9278E
P2860
New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
New candidate therapeutic agen ...... or clinical practice (review).
@ast
New candidate therapeutic agen ...... or clinical practice (review).
@en
type
label
New candidate therapeutic agen ...... or clinical practice (review).
@ast
New candidate therapeutic agen ...... or clinical practice (review).
@en
prefLabel
New candidate therapeutic agen ...... or clinical practice (review).
@ast
New candidate therapeutic agen ...... or clinical practice (review).
@en
P2093
P2860
P921
P356
P1433
P1476
New candidate therapeutic agen ...... or clinical practice (review).
@en
P2093
Arisa Ueki
Eiichiro Tominaga
Kenta Masuda
Kiyoko Umene
Kosuke Tsuji
Kouji Banno
Megumi Yanokura
Nobuyuki Susumu
Wataru Yamagami
P2860
P304
P356
10.3892/OR.2013.2221
P5008
P577
2013-01-03T00:00:00Z
2013-03-01T00:00:00Z